Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04514744

Dynamic Proteomics and Integrated Rates of Muscle Protein Synthesis During an Acute Period of Loading and Unloading

Skeletal muscle plays several different roles in the promotion and maintenance of health and well-being. The loss of muscle mass that occurs with aging, chronic muscle wasting diseases, and physical inactivity puts people at an increased risk of frailty and becoming insulin resistant, and therefore imposes a significant burden on health care spending. Resistance exercise participation has proven particularly effective for increasing muscle mass and strength. This effectiveness can be used by health care practitioners in a rehabilitation setting to promote the recovery of individuals who have undergone involuntary periods of muscular unloading (i.e. limb immobilization caused by a sports injury or reconstructive surgery). However, there is large variability in the amount of muscle mass and strength that people gain following participation in resistance exercise. Some individuals fail to increase the size of their muscle (low responders) whereas others show vary large increases in muscle size (high responders) in response to the same resistance training program. People also show differences in the amount of muscle tissue they lose when they have a limb immobilized. To circumvent variability across individuals, the investigators utilized a within-person paired Hypertrophy and Atrophy ('HYPAT') strategy that reduced response heterogeneity by ~40% (Available at: https://ssrn.com/abstract=3445673). Specifically, one leg performed resistance training for 10 weeks to induce hypertrophy, whereas the other leg underwent single-leg immobilization for 2 weeks to induce atrophy. The primary goal of the study will be to gain insight into the molecular responses to an acute period of single-leg immobilization and resistance exercise (8 days). The investigators will use an integrated systems biology approach to monitor the individual rates of over one hundred different muscle proteins.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Exercise Metabolism Research Laboratory, McMaster Univeristy

Hamilton, Ontario, L8S 4K1, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy males, between the ages of 18 and 30 y
  • Body Mass Index between 18.5 and 30.0 kg/m2
  • Able and willing to provide informed consent

Exclusion criteria

  • A history of neuromuscular disorders or muscle/bone wasting diseases.
  • Any acute or chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin-dependent or insulin-independent diabetes, or the presence of any other metabolic disease - all of which will be determined via a medical history screening questionnaire.
  • The use of any medications known to affect protein metabolism (glucocorticoids, non-steroidal anti-inflammatory medication, or prescription strength acne medication, etc.).
  • A (family) history of thrombosis.
  • The use of anticoagulant medications.
  • Consumption of tobacco-containing products.
  • Excessive alcohol consumption (>21 units/wk).
  • History of bleeding diathesis, platelet or coagulation disorders, or anti-platelet/anticoagulation therapy.
  • Exercise participation >2 days/wk (structured resistance and/or aerobic-type exercise)

Treatment and study plan

Knee bracing

Procedure

Participants will have one leg immobilized, by means of a removable Don Joy Knee Brace. Participants will be expected to keep the knee brace on for 14 days, completely prevent weight bearing on the immobilized leg, and use crutches.

Unilateral Resistance Exercise Training

Other

Participants will perform resistance training on 4 occasions throughout an 8 day time period.

Primary outcomes

  1. Change in Dynamic Proteomics

    Time frame: Baseline, Day 5, Day 9 and Day 14 (Post)

    The investigators will use deuterated water and skeletal muscle biopsies, paired with sensitive Gas Chromatography-Mass Spectrometry techniques to calculate the individual synthesis rate of over one hundred different skeletal muscle proteins.

  2. Change in Integrated Rates of Muscle Protein Synthesis

    Time frame: Baseline, Day 5, Day 9 and Day 14 (Post)

    The investigators will use deuterated water and skeletal muscle biopsies to calculate the cumulative synthesis of skeletal muscle proteins.

Secondary outcomes

  1. Change in Lean Mass Using Dual X-Ray Absorptiometry

    Time frame: Baseline, Day 5 and Day 14 (Post)

    The change in lean mass (kg) will be assessed throughout the intervention using dual X-Ray absorptiometry at baseline, Day 4, and Day 8 (Post) of the intervention

  2. Change in Muscle Strength using an Isokinetic Dynamometer

    Time frame: Baseline, Day 5 and Day 14 (Post)

    Muscle strength will be analyzed throughout the intervention using an isokinetic dynamometer. Isometric muscle torque (i.e., strength [N*m]) of the knee extensor will be measured.

  3. Change in Muscle Cross-Sectional Area using Ultrasonography

    Time frame: Baseline, Day 5 and Day 14 (Post)

    The investigators will measure changes in vastus lateralis muscle cross sectional area (cm^2) throughout the intervention using ultrasonography.

Sponsors and collaborators

Lead sponsor

McMaster University

Other

Registry information

Official study title

Dynamic Proteomics and Integrated Rates of Muscle Protein Synthesis During an Acute Period of Hypertrophy and Atrophy (HYPAT) in Young, Healthy Men

Acronym: HYPAT

Important dates

Study start
2021
Primary completion
2022
Study completion
2025
First posted
Aug 17, 2020
Registry last updated
Oct 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.